X
07Jan

DEAL WATCH: End-of-Year Biosimilar Agreements

Goodwin | | Return|
Following the string of biosimilar agreements announced in early November, a number of additional transactions were announced in early December, bringing 2019 to a roaring close with global biosimilars deals. On December 1, 2019, Luye Pharma Group...
By: Goodwin
Source Url: https://www.jdsupra.com/legalnews/deal-watch-end-of-year-biosimilar-10061/

Related

NLRB Proposes New Rules to Modify Union Election Policies

The National Labor Relations Board (the "NLRB" or "Board") issued a Notice of Proposed Rulemaking on...

Read More >

Ohio Supreme Court Crushes "Fannie Lewis Law" in Cleveland - Reverses Court of Appeals in Hot Debate

Ohio local hiring laws affecting contractors are destroyed, for now. Municipalities will no longer ...

Read More >

UPDATE: H-1B Cap Electronic Registration to Be Implemented in 2020

Employers seeking to file H-1B cap-subject petitions will need to complete an initial electronic reg...

Read More >

Governor Cuomo Signs Legislation Significantly Expanding Employee Rights Under the New York State Human Rights Law

We recently published a client alert concerning pending New York State legislation expanding worker ...

Read More >

Employees Will Be Exempted from Most Requirements of the Amended California Consumer Privacy Act … For Now

In an effort to give consumers more control over the data businesses collect from and about them, th...

Read More >

SEC Issues Final Amendments to Reporting Requirements

In May 2019, the Securities and Exchange Commission (“SEC”) proposed changes to reporting for acqu...

Read More >